Left Ventricular Free-wall Ruptrue After Acute Myocardial Infarction (LVFR-AMI)

NCT ID: NCT04172168

Last Updated: 2021-04-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

17568 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-01-01

Study Completion Date

2021-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The Left Ventricular Free-wall Ruptrue (LVFR) is a serious complication caused high mortality.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The actual mortality of LVFR is close to 100%. Despite the mortality rate for LVFR has been decreasing with the development of reperfusion therapy, the serious complication remains a difficult challenge. The coronary anatomy distribution associated with LVFR has an interesting phenomenon. From the perspective of different coronary distribution, we can better known the risk factors related to LVFR.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Myocardial Infarction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Heart rupture

Include left ventricular free-wall ruptrue after AMI

Heart rupture

Intervention Type DIAGNOSTIC_TEST

Left ventricular free-wall ruptrue after AMI

Non heart rupture

AMI with non heart rupture

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Heart rupture

Left ventricular free-wall ruptrue after AMI

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients be admitted for acute myocardial infarction (STEMI or NSTEMI)

Exclusion Criteria

* Non-cardiovascular comorbidity for AMI
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Xiamen Cardiovascular Hospital, Xiamen University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Yan Wang

President

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Yan Wang, PhD

Role: STUDY_CHAIR

Cardiovascular Hospital, Xiamen University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Xiamen Cardiovascular Hospital Xiamen University

Xiamen, Fujian, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Yan Wang, PhD

Role: CONTACT

+8613860488088

Bin Wang, PhD

Role: CONTACT

+8613400664305

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Bin Wang, Ph.D

Role: primary

+8613400664305

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

9215443689

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.